Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Alx Oncology Holdings (ALXO) Net Margin (2019 - 2020)

Alx Oncology Holdings' Net Margin history spans 2 years, with the latest figure at 2651.23% for Q2 2020.

  • On a quarterly basis, Net Margin fell 225139.0% to 2651.23% in Q2 2020 year-over-year; TTM through Mar 2021 was 10946.87%, a 1036834.0% decrease, with the full-year FY2020 number at 4309.81%, down 382460.0% from a year prior.
  • Net Margin hit 2651.23% in Q2 2020 for Alx Oncology Holdings, down from 1135.42% in the prior quarter.
  • Over the last five years, Net Margin for ALXO hit a ceiling of 327.63% in Q3 2019 and a floor of 2651.23% in Q2 2020.